NCT01915264View on ClinicalTrials.gov

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice

WithdrawnOBSERVATIONAL

0

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Acarbose/Metformin (Glucobay M, BAY81-9783)

Acarbose (25/50mg) and Metformin (500mg) in fixed dose combination.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY